Search for other papers by Helga Schultz in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Svend Aage Engelholm in
Google Scholar
PubMed
Search for other papers by Eva Harder in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Ulrik Pedersen-Bjergaard in
Google Scholar
PubMed
Search for other papers by Peter Lommer Kristensen in
Google Scholar
PubMed
Introduction In patients with malignant disease, glucocorticoids are widely used on various indications. High-dose treatment is given as part of chemotherapy regimens and for treating oedema associated with metastatic spinal cord compression
Department of Physiology and Pharmacology V. Erspamer, Sapienza University of Rome, Rome, Italy
Search for other papers by Carlo Cinque in
Google Scholar
PubMed
Search for other papers by Manuela Zinni in
Google Scholar
PubMed
Search for other papers by Anna Rita Zuena in
Google Scholar
PubMed
Search for other papers by Chiara Giuli in
Google Scholar
PubMed
Search for other papers by Sebastiano G Alemà in
Google Scholar
PubMed
Search for other papers by Assia Catalani in
Google Scholar
PubMed
Search for other papers by Paola Casolini in
Google Scholar
PubMed
Search for other papers by Roberto Cozzolino in
Google Scholar
PubMed
; however, this kind of assessment could be influenced by events, often unknown to experimenters, that took place immediately before sampling. This is particularly important for glucocorticoid hormones. Furthermore, in most cases, blood withdrawal requires
Search for other papers by Jonneke J Hollanders in
Google Scholar
PubMed
Search for other papers by Bibian van der Voorn in
Google Scholar
PubMed
Search for other papers by Noera Kieviet in
Google Scholar
PubMed
Search for other papers by Koert M Dolman in
Google Scholar
PubMed
Search for other papers by Yolanda B de Rijke in
Google Scholar
PubMed
Search for other papers by Erica L T van den Akker in
Google Scholar
PubMed
Search for other papers by Joost Rotteveel in
Google Scholar
PubMed
Department of Psychiatry, VU University Medical Center, Amsterdam, The Netherlands
Search for other papers by Adriaan Honig in
Google Scholar
PubMed
Search for other papers by Martijn J J Finken in
Google Scholar
PubMed
Introduction Prenatal exposure to excessive glucocorticoids (GCs) has been associated with an increased risk of cardiovascular diseases and depressive disorders ( 1 , 2 ). This might be due to permanent alterations in the settings of the
Search for other papers by Brijesh Krishnappa in
Google Scholar
PubMed
Search for other papers by Ravikumar Shah in
Google Scholar
PubMed
Search for other papers by Saba Samad Memon in
Google Scholar
PubMed
Search for other papers by Chakra Diwaker in
Google Scholar
PubMed
Search for other papers by Anurag R Lila in
Google Scholar
PubMed
Search for other papers by Virendra A Patil in
Google Scholar
PubMed
Search for other papers by Nalini S Shah in
Google Scholar
PubMed
Search for other papers by Tushar R Bandgar in
Google Scholar
PubMed
therapies ( 1 ). The remaining treatment options include observation or glucocorticoid therapy and each of them can be used as the primary treatment based on clinical scenario. A recent meta-analysis concluded that patients with milder presentation be
Search for other papers by V Guarnotta in
Google Scholar
PubMed
Search for other papers by C Di Stefano in
Google Scholar
PubMed
Search for other papers by A Santoro in
Google Scholar
PubMed
Search for other papers by A Ciresi in
Google Scholar
PubMed
Search for other papers by A Coppola in
Google Scholar
PubMed
Search for other papers by C Giordano in
Google Scholar
PubMed
Introduction Adrenal insufficiency (AI) is characterized by high morbidity and mortality, likely due to inappropriate glucocorticoid (GC) treatment and no physiological daily exposure. Indeed, conventional GC treatment, with hydrocortisone (HC
Search for other papers by Kathrin Zopf in
Google Scholar
PubMed
Search for other papers by Kathrin R Frey in
Google Scholar
PubMed
Search for other papers by Tina Kienitz in
Google Scholar
PubMed
Search for other papers by Manfred Ventz in
Google Scholar
PubMed
Search for other papers by Britta Bauer in
Google Scholar
PubMed
Search for other papers by Marcus Quinkler in
Google Scholar
PubMed
Introduction Polymorphisms of the glucocorticoid receptor (GR) may influence the sensitivity to glucocorticoids by altering the GR expression (e.g. reducing transcription) and influencing transactivation and transrepression of target genes
Search for other papers by David J F Smith in
Google Scholar
PubMed
Search for other papers by Hemanth Prabhudev in
Google Scholar
PubMed
Department of Clinical Biochemistry, Imperial College Healthcare NHS Trust, London, UK
Department of Investigative Medicine, Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK
Search for other papers by Sirazum Choudhury in
Google Scholar
PubMed
Department of Investigative Medicine, Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK
Search for other papers by Karim Meeran in
Google Scholar
PubMed
Introduction Adrenal insufficiency (AI) is caused either by primary adrenal failure or secondary impairment of the hypothalamic–pituitary–adrenal axis ( 1 ). Both result in glucocorticoid deficiency with additional impairment of
Search for other papers by Anastasia P Athanasoulia-Kaspar in
Google Scholar
PubMed
Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ludwig-Maximilians-Universität München, Munich, Germany
Search for other papers by Matthias K Auer in
Google Scholar
PubMed
Search for other papers by Günter K Stalla in
Google Scholar
PubMed
Search for other papers by Mira Jakovcevski in
Google Scholar
PubMed
, high doses of glucocorticoid substitution therapy and older age at diagnosis are the most consistently identified risk factors associated with increased morbidity and mortality ( 18 , 19 ). In addition, growth hormone deficiency (GHD) has been linked
Center for Healthy Aging, Technische Universität Dresden, Dresden, Germany
Search for other papers by Sylvia Thiele in
Google Scholar
PubMed
Search for other papers by Anke Hannemann in
Google Scholar
PubMed
Center for Healthy Aging, Technische Universität Dresden, Dresden, Germany
Search for other papers by Maria Winzer in
Google Scholar
PubMed
Center for Healthy Aging, Technische Universität Dresden, Dresden, Germany
Search for other papers by Ulrike Baschant in
Google Scholar
PubMed
Center for Healthy Aging, Technische Universität Dresden, Dresden, Germany
Search for other papers by Heike Weidner in
Google Scholar
PubMed
Search for other papers by Matthias Nauck in
Google Scholar
PubMed
Search for other papers by Rajesh V Thakker in
Google Scholar
PubMed
DFG Research Center and Cluster of Excellence for Regenerative Therapies, Technical University, Dresden, Germany
Search for other papers by Martin Bornhäuser in
Google Scholar
PubMed
Center for Healthy Aging, Technische Universität Dresden, Dresden, Germany
DFG Research Center and Cluster of Excellence for Regenerative Therapies, Technical University, Dresden, Germany
Search for other papers by Lorenz C Hofbauer in
Google Scholar
PubMed
Center for Healthy Aging, Technische Universität Dresden, Dresden, Germany
Search for other papers by Martina Rauner in
Google Scholar
PubMed
Introduction Glucocorticoids (GCs) are effective drugs in the treatment of immune-mediated diseases, including rheumatoid arthritis or allergic diseases such as asthma. However, their administration is often accompanied by adverse effects on
Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Margret J Einarsdottir in
Google Scholar
PubMed
Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Penelope Trimpou in
Google Scholar
PubMed
Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Gudmundur Johannsson in
Google Scholar
PubMed
Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden
Wallenberg Center for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Oskar Ragnarsson in
Google Scholar
PubMed
Introduction Oral glucocorticoid (GC) treatment can lead to adrenal insufficiency by suppressing the hypothalamic–pituitary–adrenal axis. This can result in life-threatening adrenal crisis if the patient does not receive an increased GC dose